Trial Profile

A MULTICENTER, OPEN-LABEL, SINGLE ARM STUDY OF THE EFFICACY AND SAFETY OF COMBINATION APREMILAST AND TOPICAL THERAPY IN SUBJECTS WITH MODERATE PLAQUE PSORIASIS WHO HAVE NOT RESPONDED ADEQUATELY TO TOPICAL TREATMENTS ALONE

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 15 Jun 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

11 Jun 2022 Results published in the Dermatology and Therapy
25 Mar 2022 According to an Amgen media release, data will be presented at the American Academy of Dermatology (AAD) congress.
13 Sep 2021 According to an Amgen media release, data from the study will be presented at the European Academy of Dermatology and Venereology (EADV) 30th Congress 2021.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com